Recursion Pharmaceuticals, Inc. (RXRX)
4.005
-0.36
(-8.14%)
USD |
NASDAQ |
Oct 12, 16:00
4.00
0.00 (0.00%)
After-Hours: 20:00
Recursion Pharmaceuticals Total Return Level : 4.36 for Oct. 9, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 09, 2026 | 4.36 |
| October 08, 2026 | 3.95 |
| October 07, 2026 | 4.27 |
| October 06, 2026 | 4.63 |
| October 05, 2026 | 4.78 |
| October 02, 2026 | 4.12 |
| October 01, 2026 | 4.07 |
| September 30, 2026 | 4.13 |
| September 29, 2026 | 4.03 |
| September 28, 2026 | 3.70 |
| September 25, 2026 | 3.74 |
| September 24, 2026 | 3.89 |
| September 23, 2026 | 3.70 |
| September 22, 2026 | 4.05 |
| September 21, 2026 | 3.97 |
| September 18, 2026 | 3.83 |
| September 17, 2026 | 3.54 |
| September 16, 2026 | 3.19 |
| September 15, 2026 | 3.24 |
| September 14, 2026 | 3.41 |
| September 11, 2026 | 3.20 |
| September 10, 2026 | 3.16 |
| September 09, 2026 | 3.215 |
| September 08, 2026 | 3.44 |
| September 04, 2026 | 3.63 |
| Date | Value |
|---|---|
| September 03, 2026 | 3.44 |
| September 02, 2026 | 3.38 |
| September 01, 2026 | 3.33 |
| August 31, 2026 | 3.40 |
| August 28, 2026 | 3.34 |
| August 27, 2026 | 3.44 |
| August 26, 2026 | 3.49 |
| August 25, 2026 | 3.56 |
| August 24, 2026 | 3.25 |
| August 21, 2026 | 3.50 |
| August 20, 2026 | 3.34 |
| August 19, 2026 | 3.50 |
| August 18, 2026 | 3.09 |
| August 17, 2026 | 3.11 |
| August 14, 2026 | 3.16 |
| August 13, 2026 | 3.31 |
| August 12, 2026 | 3.29 |
| August 11, 2026 | 3.35 |
| August 10, 2026 | 3.29 |
| August 07, 2026 | 3.22 |
| August 06, 2026 | 3.18 |
| August 05, 2026 | 3.17 |
| August 04, 2026 | 3.31 |
| August 03, 2026 | 3.18 |
| July 31, 2026 | 3.00 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Absci Corp. | 10.16 |
| Twist Bioscience Corp. | 159.78 |
| Editas Medicine, Inc. | 2.90 |
| Amgen, Inc. | 621.24 |
| Halozyme Therapeutics, Inc. | 110.42 |